Laigo Bio completes final close of €17m seed financing round
Laigo Bio has completed the second close of its seed financing round at €5.5m, bringing the total raised to €17m
Read MoreLaigo Bio has completed the second close of its seed financing round at €5.5m, bringing the total raised to €17m
Read MoreAEON Biopharma, a biopharmaceutical company, has appointed John Bencich as Chief Financial Officer (CFO)
Read MoreAxplora has announced plans to build a 4,500sqm R&D and laboratory hub at its Farmabios site in Gropello Cairoli in Italy
Read MoreHelus Pharma, a clinical stage pharmaceutical company focused on developing novel serotonergic agonists (NSAs), has appointed Jill Conwell as Chief People Officer, effective immediately
Read MoreDNA Script has signed distribution agreements with Gencell, Bio-Medical Science (BMS) and Biostream, expanding global access to its SYNTAX platform.
Read More




PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
